Lyrica Safety: 10 Things You Should Know

Lyrica (pregabalin) was approved by the U.S. Food and Drug Administration for treating fibromyalgia in adults 18 years and older on June 21, 2007. Until the approval of Lyrica capsules (pronounced LEER-i-kah), no medicine was specifically approved for the treatment of fibromyalgia. Lyrica has antiepileptic, analgesic, and anxiolytic properties and is chemically and structurally similar to the drug Neurontin (gabapentin), according to Gold Standard.

The effectiveness of Lyrica for treating fibromyalgia was established by two clinical trials involving 1,800 people. Study results from the two randomized, double-blind, placebo-controlled clinical trials showed that doses of 300 mg. or 450 mg. of Lyrica per day improved fibromyalgia symptoms (i.e., reduced pain and improved function) as early as the first week of treatment. When patients stopped taking Lyrica capsules, fibromyalgia symptoms worsened.

• How do Lyrica capsules work?
• What possible drug interactions may occur with Lyrica?
• What are the safety warnings for Lyrica capsules?
• What are the potential side effects of Lyrica?

Lyrica safety is important for fibromyalgia patients. Lyrica safety decreases the chance for undesirable side effects. Lyrica must be taken according to directions. If you take the drug, here are 10 Things You Should Know About Lyrica.

Related Resources:

• How is Fibromyalgia Treated?
• Fast Facts About Fibromyalgia
• Test Your Knowledge: Fibromyalgia
• Fibromyalgia 101: Free E-Course Newsletter
• 10 Things You Should Know About Fibromyalgia

Join the Discussion:

• Join Us in Our Arthritis Forum

_{Image © A.D.A.M.}